| Macro demand | Cannabis-tourism projected US $ 23.7 Bn by 2030, CAGR ≈ 12 % | (Grand View Research) |
| Medical-spa / wellness-resort market to reach US $ 49.4 Bn by 2030, CAGR 15 % | (Grand View Research) |
| Global wellness-tourism spend US $ 830 Bn (2023) | (Global Wellness Institute) |
| 9.7 M cancer deaths (2020) underpin late-stage demand | (ACS Publications) |
| High-net-worth oncology tourists spend US $ 20-50 k per stay | (PMC) |
| Launch geography | 4-ha sacramental site adjacent to Dominica’s new 2 850 m runway airport (opening 2026; 5-min shuttle) | (Global Citizen Solutions) |
| Regulatory tail-wind | By-products Bill to legalise infused F&B and on-site consumption by Q4 2025 | (Loop News) |
| Infrastructure boost | Airport unlocks direct EU/NA routes; Dominican stay-over arrivals 83 976 (2024, +13 % YoY) | (Global Citizen Solutions, Loop News) |
| Concept – “Sativa Center” | 20 ocean-view oncology villa-suites (90 m²), GMP tincture lab, clinical-grade spa, daily raw-cannabis protocols, ISC Safe-Serve seal | — |
| Phase 1 (2025-26) | Launch 10 suites exclusively for terminal cancer patients referred by Dr William Courtney; reservation-only 21-day stays at US $ 600 / night; 70 % OCC target | internal model |
| Phase 2 (2027) | Expand to 20 suites, double spa+lab, create global oncologist referral network; leverage new airport traffic | — |
| Revenue model (Y1) | Room + therapy ≈ US $ 3.1 M; add-on F&B/lab sales ≈ US $ 0.9 M → US $ 4 M gross; 58 % blended margin (benchmarked to oncology retreats in Mexico & Thailand) | (PMC) |
| Financial plan | EBITDA Y1 ≈ US $ 1.1 M; IRR ≈ 38 % on 5-year base case | internal model |
| Seed ask & use | US $ 5 M: 50 % villas/clinic • 20 % lab & spa fit-out • 15 % oncology equipment • 10 % marketing • 5 % contingency | — |
| Investor menu | Equity ≥ US $ 250 k (shares, dividends, 7-yr buy-back)Revenue-Share Note US $ 100-250 k (8 % gross receipts until 1.5× repaid, then 3 %)Founding Member ISC US $ 10 k/yr (lifetime villa upgrades + priority oncology slots) | — |
| ISC edge | ISC brings Dr William Courtney MD (thousands of raw-cannabis remissions) plus certified Ital chefs & healers, files all compliance and bundles a turnkey expansion kit for Saint Lucia & Jamaica | — |
| Risks / mitigation | Law delay → hemp/CBD fallback; supply risk → GMP contracts; stigma → data-backed micro-dose education; runway noise → sound-proof eco facades | — |
| ESG impact | 75 % local sourcing, solar & rainwater, waste-to-compost, healer equity pool, clinical data shared open-access | — |
| Contact | investor@is-cannabis.com | — |
